Schiavoni, V.; Di Crescenzo, T.; Membrino, V.; Alia, S.; Fantone, S.; Salvolini, E.; Vignini, A.
Bardoxolone Methyl: A Comprehensive Review of Its Role as a Nrf2 Activator in Anticancer Therapeutic Applications. Pharmaceuticals 2025, 18, 966.
https://doi.org/10.3390/ph18070966
AMA Style
Schiavoni V, Di Crescenzo T, Membrino V, Alia S, Fantone S, Salvolini E, Vignini A.
Bardoxolone Methyl: A Comprehensive Review of Its Role as a Nrf2 Activator in Anticancer Therapeutic Applications. Pharmaceuticals. 2025; 18(7):966.
https://doi.org/10.3390/ph18070966
Chicago/Turabian Style
Schiavoni, Valentina, Tiziana Di Crescenzo, Valentina Membrino, Sonila Alia, Sonia Fantone, Eleonora Salvolini, and Arianna Vignini.
2025. "Bardoxolone Methyl: A Comprehensive Review of Its Role as a Nrf2 Activator in Anticancer Therapeutic Applications" Pharmaceuticals 18, no. 7: 966.
https://doi.org/10.3390/ph18070966
APA Style
Schiavoni, V., Di Crescenzo, T., Membrino, V., Alia, S., Fantone, S., Salvolini, E., & Vignini, A.
(2025). Bardoxolone Methyl: A Comprehensive Review of Its Role as a Nrf2 Activator in Anticancer Therapeutic Applications. Pharmaceuticals, 18(7), 966.
https://doi.org/10.3390/ph18070966
